The present invention relates to a method for decreasing elevated
serum/plasma LDL-cholesterol levels or LDL-cholesterol levels and CRP
levels in a mammal in need thereof. The methods comprises administering an
effective amount of a tetracycline formulation. In one embodiment, the
tetracycline formulation is a non-antibacterial tetracycline. In another
embodiment, the tetracycline formulation is an antibacterial tetracycline
at a sub-antibacterial amount.
